iih glp 1 Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention GLP-1 receptor agonists may improve
Description
Exenatide immediate-release (Byetta): Initiation involves a 5 mcg dose administered subcutaneously twice daily, which can be increased to 10 mcg twice daily after a month if required
Read the full Terms and Conditions before relying on this feature as a safety net
Disclosure The authors declare no conflicts of interest in this work
(2014) 9:e94891
The rising use of these treatments in patients without diabetes has increased demand and raised questions about access for those with diabetes and obesity
